EuroGuiDerm寻常型银屑病的全身治疗指南-第2部分:特定的临床和合并症

2021-02-03 欧洲皮肤病学论坛 J Eur Acad Dermatol Venereol . 2021 Feb;35(2):281-317

该基于证据和共识的寻常型银屑病治疗指南是根据《 EuroGuiDerm指南和共识声明开发手册》制定的。 指南的第二部分为特定的临床和合并症提供了指导,例如治疗寻常型银屑病并发银屑病关节炎,并发炎性肠病

中文标题:

EuroGuiDerm寻常型银屑病的全身治疗指南-第2部分:特定的临床和合并症

发布机构:

欧洲皮肤病学论坛

发布日期:

2021-02-03

简要介绍:

该基于证据和共识的寻常型银屑病治疗指南是根据《 EuroGuiDerm指南和共识声明开发手册》制定的。 指南的第二部分为特定的临床和合并症提供了指导,例如治疗寻常型银屑病并发银屑病关节炎,并发炎性肠病,恶性肿瘤病史或抑郁或自杀意念的患者。 它还提出了有关糖尿病,病毒性肝炎,影响心脏或肾脏的疾病以及神经系统疾病的建议。提供了有关如何筛查结核病的建议,以及有关如何管理结核病检测结果呈阳性的患者的建议。它进一步涵盖了在不久的将来对孕妇或希望生育孩子的患者的治疗。 还提供了有关COVID-19大流行期间的疫苗接种,免疫原性和全身治疗的信息。

第一部分见:EuroGuiDerm寻常型银屑病全身治疗指南-第1部分:治疗和监测建议

相关资料下载:
[AttachmentFileName(sort=1, fileName=jdv.16926.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cf9511c00205a047, title=EuroGuiDerm寻常型银屑病的全身治疗指南-第2部分:特定的临床和合并症 , enTitle=, guiderFrom=J Eur Acad Dermatol Venereol . 2021 Feb;35(2):281-317, authorId=0, author=, summary=该基于证据和共识的寻常型银屑病治疗指南是根据《 EuroGuiDerm指南和共识声明开发手册》制定的。 指南的第二部分为特定的临床和合并症提供了指导,例如治疗寻常型银屑病并发银屑病关节炎,并发炎性肠病, cover=, journalId=0, articlesId=null, associationId=450, associationName=欧洲皮肤病学论坛, associationIntro=The practice of dermatology has, over the past 30 years, been distinguished by its transition from provision of essentially empirical treatments to a practice in which rational therapies, based on enhanced knowledge of the pathogenesis of disease, are administered. Coincidentally, the boundaries between organ specific specialities such as our own have become blurred. Thus there is now great overlap with numerous other medical disciplines. These include: oncology, immunology / allergology, plastic surgery, oral medicine and, increasingly rheumatology and other disciplines in which management of chronic inflammatory disease plays an important role., copyright=0, guiderPublishedTime=Wed Feb 03 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">该基于证据和共识的寻常型银屑病治疗指南是根据《 EuroGuiDerm指南和共识声明开发手册》制定的。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="1">指南的第二部分为特定的临床和合并症提供了指导,例如治疗寻常型银屑病并发银屑病关节炎,并发炎性肠病,恶性肿瘤病史或抑郁或自杀意念的患者。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="2">它还提出了有关糖尿病,病毒性肝炎,影响心脏或肾脏的疾病以及神经系统疾病的建议。</span></span><span lang="zh-CN">提供了有关如何筛查结核病的建议,以及有关如何管理结核病检测结果呈阳性的患者的建议。</span><span lang="zh-CN">它进一步涵盖了在不久的将来对孕妇或希望生育孩子的患者的治疗。 还提供了有关COVID-19大流行期间的疫苗接种,免疫原性和全身治疗的信息。</span></p> <p><span lang="zh-CN">第一部分见:<a href="https://www.medsci.cn/guideline/show_article.do?id=83a531c00205a1b7" target="_blank" rel="noopener">EuroGuiDerm寻常型银屑病全身治疗指南-第1部分:治疗和监测建议</a></span></p>, tagList=[TagDto(tagId=4418, tagName=银屑病)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤与性病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7647, appHits=100, showAppHits=0, pcHits=562, showPcHits=7547, likes=2, shares=14, comments=10, approvalStatus=1, publishedTime=Wed Feb 10 19:57:48 CST 2021, publishedTimeString=2021-02-03, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=fbzhang, createdTime=Wed Feb 10 19:55:20 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 20:36:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=jdv.16926.pdf)])
jdv.16926.pdf
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082041, encodeId=d1a010820417e, content=指南学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20731603742, createdName=ihvv, createdTime=Mon Dec 20 11:13:20 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051857, encodeId=8de1105185efe, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:42 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004044, encodeId=8b0a100404406, content=感谢🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef85166597, createdName=杨敏, createdTime=Fri Jul 30 22:04:55 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950388, encodeId=7cdc950388fc, content=www.wfjdyy.com, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:05:03 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950387, encodeId=6f5e95038ec8, content=<a href='/topic/show?id=a27c1039589a' target=_blank style='color:#2F92EE;'>#插入话题#</a> 怎样获取积分啊?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103958, encryptionId=a27c1039589a, topicName=插入话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:04:51 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-12-20 ihvv

    指南学习中

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082041, encodeId=d1a010820417e, content=指南学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20731603742, createdName=ihvv, createdTime=Mon Dec 20 11:13:20 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051857, encodeId=8de1105185efe, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:42 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004044, encodeId=8b0a100404406, content=感谢🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef85166597, createdName=杨敏, createdTime=Fri Jul 30 22:04:55 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950388, encodeId=7cdc950388fc, content=www.wfjdyy.com, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:05:03 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950387, encodeId=6f5e95038ec8, content=<a href='/topic/show?id=a27c1039589a' target=_blank style='color:#2F92EE;'>#插入话题#</a> 怎样获取积分啊?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103958, encryptionId=a27c1039589a, topicName=插入话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:04:51 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082041, encodeId=d1a010820417e, content=指南学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20731603742, createdName=ihvv, createdTime=Mon Dec 20 11:13:20 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051857, encodeId=8de1105185efe, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:42 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004044, encodeId=8b0a100404406, content=感谢🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef85166597, createdName=杨敏, createdTime=Fri Jul 30 22:04:55 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950388, encodeId=7cdc950388fc, content=www.wfjdyy.com, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:05:03 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950387, encodeId=6f5e95038ec8, content=<a href='/topic/show?id=a27c1039589a' target=_blank style='color:#2F92EE;'>#插入话题#</a> 怎样获取积分啊?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103958, encryptionId=a27c1039589a, topicName=插入话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:04:51 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-07-30 杨敏

    感谢🙏

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1082041, encodeId=d1a010820417e, content=指南学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20731603742, createdName=ihvv, createdTime=Mon Dec 20 11:13:20 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051857, encodeId=8de1105185efe, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:42 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004044, encodeId=8b0a100404406, content=感谢🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef85166597, createdName=杨敏, createdTime=Fri Jul 30 22:04:55 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950388, encodeId=7cdc950388fc, content=www.wfjdyy.com, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:05:03 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950387, encodeId=6f5e95038ec8, content=<a href='/topic/show?id=a27c1039589a' target=_blank style='color:#2F92EE;'>#插入话题#</a> 怎样获取积分啊?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103958, encryptionId=a27c1039589a, topicName=插入话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:04:51 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-03-23 黎庶

    www.wfjdyy.com

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1082041, encodeId=d1a010820417e, content=指南学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=20731603742, createdName=ihvv, createdTime=Mon Dec 20 11:13:20 CST 2021, time=2021-12-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051857, encodeId=8de1105185efe, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:31:42 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004044, encodeId=8b0a100404406, content=感谢🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ef85166597, createdName=杨敏, createdTime=Fri Jul 30 22:04:55 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950388, encodeId=7cdc950388fc, content=www.wfjdyy.com, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:05:03 CST 2021, time=2021-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950387, encodeId=6f5e95038ec8, content=<a href='/topic/show?id=a27c1039589a' target=_blank style='color:#2F92EE;'>#插入话题#</a> 怎样获取积分啊?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103958, encryptionId=a27c1039589a, topicName=插入话题)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202148/1617894843737_1614372.png, createdBy=7d195472410, createdName=黎庶, createdTime=Tue Mar 23 16:04:51 CST 2021, time=2021-03-23, status=1, ipAttribution=)]
    2021-03-23 黎庶

    #插入话题# 怎样获取积分啊?

    0